• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过旋转蒸发和KinetiSol分散法制备无定形固体分散体:提高难溶性树胶提取物溶解度的方法

Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract.

作者信息

Bennett Ryan C, Brough Chris, Miller Dave A, O'Donnell Kevin P, Keen Justin M, Hughey Justin R, Williams Robert O, McGinity James W

机构信息

Division of Pharmaceutics, The University of Texas at Austin , Austin, TX , USA .

出版信息

Drug Dev Ind Pharm. 2015 Mar;41(3):382-97. doi: 10.3109/03639045.2013.866142. Epub 2013 Dec 16.

DOI:10.3109/03639045.2013.866142
PMID:24329130
Abstract

Acetyl-11-keto-β-boswellic acid (AKBA), a gum resin extract, possesses poor water-solubility that limits bioavailability and a high melting point making it difficult to successfully process into solid dispersions by fusion methods. The purpose of this study was to investigate solvent and thermal processing techniques for the preparation of amorphous solid dispersions (ASDs) exhibiting enhanced solubility, dissolution rates and bioavailability. Solid dispersions were successfully produced by rotary evaporation (RE) and KinetiSol® Dispersing (KSD). Solid state and chemical characterization revealed that ASD with good potency and purity were produced by both RE and KSD. Results of the RE studies demonstrated that AQOAT®-LF, AQOAT®-MF, Eudragit® L100-55 and Soluplus with the incorporation of dioctyl sulfosuccinate sodium provided substantial solubility enhancement. Non-sink dissolution analysis showed enhanced dissolution properties for KSD-processed solid dispersions in comparison to RE-processed solid dispersions. Variances in release performance were identified when different particle size fractions of KSD samples were analyzed. Selected RE samples varying in particle surface morphologies were placed under storage and exhibited crystalline growth following solid-state stability analysis at 12 months in comparison to stored KSD samples confirming amorphous instability for RE products. In vivo analysis of KSD-processed solid dispersions revealed significantly enhanced AKBA absorption in comparison to the neat, active substance.

摘要

乙酰-11-酮-β-乳香酸(AKBA)是一种树胶脂提取物,其水溶性较差,这限制了其生物利用度,且熔点较高,使得通过熔融法成功加工成固体分散体变得困难。本研究的目的是研究溶剂和热加工技术,以制备具有增强溶解度、溶解速率和生物利用度的无定形固体分散体(ASD)。通过旋转蒸发(RE)和KinetiSol®分散法(KSD)成功制备了固体分散体。固态和化学表征表明,RE和KSD均能制备出具有良好效能和纯度的ASD。RE研究结果表明,加入琥珀酸二辛酯磺酸钠的AQOAT®-LF、AQOAT®-MF、Eudragit® L100-55和Soluplus具有显著的溶解度增强效果。非漏槽溶解分析表明,与RE处理的固体分散体相比,KSD处理的固体分散体具有增强的溶解性能。分析KSD样品的不同粒径级分时,发现释放性能存在差异。将选定的具有不同颗粒表面形态的RE样品进行储存,与储存的KSD样品相比,在12个月的固态稳定性分析后,RE样品出现了晶体生长,这证实了RE产品的无定形不稳定性。对KSD处理的固体分散体的体内分析表明,与纯活性物质相比,AKBA的吸收显著增强。

相似文献

1
Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract.通过旋转蒸发和KinetiSol分散法制备无定形固体分散体:提高难溶性树胶提取物溶解度的方法
Drug Dev Ind Pharm. 2015 Mar;41(3):382-97. doi: 10.3109/03639045.2013.866142. Epub 2013 Dec 16.
2
Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion.通过 KinetoSol 分散法对伊曲康唑固体分散体的熔融加工:与热熔挤出法的比较研究。
J Pharm Sci. 2010 Mar;99(3):1239-53. doi: 10.1002/jps.21893.
3
Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing.通过KinetiSol®分散技术实现利托那韦-聚乙烯醇无定形固体分散体的热加工。
Eur J Pharm Biopharm. 2016 Apr;101:72-81. doi: 10.1016/j.ejpb.2016.01.018. Epub 2016 Feb 6.
4
Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.KinetiSol 分散剂在无增塑剂无定形固体分散体生产中的应用。
Eur J Pharm Sci. 2010 Jun 14;40(3):179-87. doi: 10.1016/j.ejps.2010.03.002. Epub 2010 Mar 15.
5
Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol dispersing.通过熔融加工增强具有热分解和酸分解特性的药物的溶出度:热熔挤出法和 KinetiSol 分散法的比较研究。
AAPS PharmSciTech. 2010 Jun;11(2):760-74. doi: 10.1208/s12249-010-9431-y. Epub 2010 May 5.
6
Thermal processing of a poorly water-soluble drug substance exhibiting a high melting point: the utility of KinetiSol® Dispersing.高热熔点难溶性药物的热加工处理:KinetiSol® Dispersing 的应用。
Int J Pharm. 2011 Oct 31;419(1-2):222-30. doi: 10.1016/j.ijpharm.2011.08.007. Epub 2011 Aug 16.
7
Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing.KinetiSol® 工艺制备无定形固体分散体提高维莫非尼的溶出度和药代动力学。
AAPS PharmSciTech. 2018 Jul;19(5):1957-1970. doi: 10.1208/s12249-018-0988-1. Epub 2018 Mar 14.
8
Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.热熔挤出和 Kinetisol 分散法制备含热敏性活性成分的固体分散体的融合生产。
Eur J Pharm Biopharm. 2010 Feb;74(2):340-51. doi: 10.1016/j.ejpb.2009.09.007. Epub 2009 Oct 7.
9
Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).使用聚乙烯醇作为难溶性药物递送的增溶聚合物(第1部分)。
AAPS PharmSciTech. 2016 Feb;17(1):167-79. doi: 10.1208/s12249-015-0458-y. Epub 2015 Dec 4.
10
Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.热加工创新:热熔挤出和 KinetiSol® 分散技术。
AAPS PharmSciTech. 2020 Nov 8;21(8):312. doi: 10.1208/s12249-020-01854-2.

引用本文的文献

1
Comment on Hermeling et al. Nano-Dry-Melting: A Novel Technology for Manufacturing of Pharmaceutical Amorphous Solid Dispersions. 2022, , 2145.关于赫梅林等人的评论:纳米干熔法——一种制备药物无定形固体分散体的新技术。2022年,,2145。 (原文中“2022, , 2145”表述似乎不太完整规范,可能影响准确理解,你可检查确认下原文信息)
Pharmaceutics. 2025 May 29;17(6):714. doi: 10.3390/pharmaceutics17060714.
2
Advancing the Physicochemical Properties and Therapeutic Potential of Plant Extracts Through Amorphous Solid Dispersion Systems.通过无定形固体分散体系统提升植物提取物的物理化学性质及治疗潜力
Polymers (Basel). 2024 Dec 14;16(24):3489. doi: 10.3390/polym16243489.
3
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.
无定形固体分散体作为癌症治疗中的药物递送载体
Polymers (Basel). 2023 Aug 11;15(16):3380. doi: 10.3390/polym15163380.
4
Development and Characterization of Eudragit EPO-Based Solid Dispersion of Rosuvastatin Calcium to Foresee the Impact on Solubility, Dissolution and Antihyperlipidemic Activity.基于Eudragit EPO的瑞舒伐他汀钙固体分散体的开发与表征,以预测其对溶解度、溶出度和抗高血脂活性的影响。
Pharmaceuticals (Basel). 2022 Apr 18;15(4):492. doi: 10.3390/ph15040492.
5
Sustained-Release Solid Dispersion of High-Melting-Point and Insoluble Resveratrol Prepared through Hot Melt Extrusion to Improve Its Solubility and Bioavailability.采用热熔挤出技术制备高熔点难溶性白藜芦醇的固体分散体以提高其溶解度和生物利用度
Molecules. 2021 Aug 17;26(16):4982. doi: 10.3390/molecules26164982.
6
Overview of the Manufacturing Methods of Solid Dispersion Technology for Improving the Solubility of Poorly Water-Soluble Drugs and Application to Anticancer Drugs.提高难溶性药物溶解度的固体分散技术制备方法概述及其在抗癌药物中的应用
Pharmaceutics. 2019 Mar 19;11(3):132. doi: 10.3390/pharmaceutics11030132.
7
The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.重组无序的无定形药物制剂科学的必要性。
Pharm Res. 2017 Sep;34(9):1754-1772. doi: 10.1007/s11095-017-2174-7. Epub 2017 May 18.
8
Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.非晶态固体分散体热加工中的挑战与策略:综述
AAPS PharmSciTech. 2016 Feb;17(1):43-55. doi: 10.1208/s12249-015-0393-y. Epub 2015 Aug 26.